Search Results for "Eylea"

Diabetic Eye Disease: What's Next for Your Patients?

Rishi Singh, MD; and Nathan Steinle, MD

Eylea real-life case studies

S. James Talks, MD

Phase 2/3 Clinical Trial Data for EYLEA HD® (aflibercept) Injection 8 mg for the Treatment of DME

Daniel F. Kiernan, MD, FACS; Prethy Rao, MD, MPH, FACS; Andrew M. Schimel, MD

Phase 3 Clinical Trial Data for EYLEA HD® (aflibercept) Injection 8 mg for the Treatment of Wet AMD

Daniel F. Kiernan, MD, FACS; Prethy Rao, MD, MPH, FACS; Andrew M. Schimel, MD

Aflibercept: the molecule

Patricia Udaondo, MD

Head-to-Head Trials

Pravin Dugel, MD

ASSESS Study - 24 Months

Rishi P. Singh, MD

Key Points From the Phase 3 PANORAMA Study

Charles C. Wykoff, MD, PhD, FACS

Protocol AC: Step Therapy in DME

Chirag D. Jhaveri, MD; and Prof. Ramin Tadayoni

View More